The Cost-Effectiveness of Combination Treatment Consisting of Either Cetuximab or Panitumumab plus FOLFIRI versus Treatment with Bevacizumab plus FOLFIRI as First-Line Treatment for KRAS Wild-Type Metastatic Colorectal Cancer Patients in Ontario

作者: Emmanuel M.G. Ewara

DOI:

关键词:

摘要:

参考文章(96)
M.Wasif Saif, Richard Kim, Edward Chu, Cytotoxic Chemotherapy for Metastatic Colorectal Cancer Humana Press. pp. 69- 84 ,(2007) , 10.1007/978-1-59745-215-1_4
William M. Grady, Molecular Biology of Colon Cancer Humana Press. pp. 1- 31 ,(2007) , 10.1007/978-1-59745-215-1_1
Nicolas Porquet, Stéphanie Gout, Jacques Huot, The Metastatic Process: An Overview Springer, Dordrecht. pp. 1- 31 ,(2010) , 10.1007/978-90-481-8833-8_1
Mark J Sculpher, Karl Claxton, Andrew Briggs, Decision Modelling for Health Economic Evaluation ,(2006)
John M. Strother, Charles D. Blanke, Integration of Antiangiogenic Strategies Into Colorectal Cancer Treatment Humana Press. pp. 85- 98 ,(2007) , 10.1007/978-1-59745-215-1_5
Nabeel Shalan, Paulo M. Hoff, The Role of EGFR Inhibition in Colorectal Cancer Humana Press. pp. 99- 118 ,(2007) , 10.1007/978-1-59745-215-1_6
Christoph Lengauer, Kenneth W. Kinzler, Bert Vogelstein, Genetic instabilities in human cancers Nature. ,vol. 396, pp. 643- 649 ,(1998) , 10.1038/25292
Karen Tu, Zhong-Liang Chen, Norman Rc Campbell, Finlay A McAlister, Karen J Cauch-Dudek, Accuracy of administrative databases in identifying patients with hypertension. Open Medicine. ,vol. 1, pp. 18- 26 ,(2007)
Terry Mashtare, Marwan Fakih, Maher Saifo, Ila R Tamaskar, Ramkumar Bhuvaneswari, Neelesh Sharma, KRAS status and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFOX chemotherapy Journal of gastrointestinal oncology. ,vol. 1, pp. 90- 96 ,(2010) , 10.3978/J.ISSN.2078-6891.2010.022